Janet B. Serle
- PROFESSOR Ophthalmology
Dr. Janet Serle is Professor of Ophthalmology and the Director of both the Glaucoma Clinical and Research Fellowships at the Mount Sinai School of Medicine. She has been a member of the full-time faculty at Mount Sinai since 1985.
Dr. Serle graduated from Harvard Medical School and did her internship in general surgery at Roosevelt Hospital in New York City. She then did a glaucoma research fellowship, a residency in ophthalmology, and a glaucoma clinical fellowship at the Mount Sinai Medical Center.
Dr. Serle has received numerous awards, including an Honor Award from the American Academy of Ophthalmology. Dr. Serle has been a Principal Investigator on more than 25 N.I.H. or industry sponsored research grants and has published over 50 peer-reviewed articles and chapters. Dr. Serle's research includes investigations of new medications, new surgical treatments, use of technology, and outcomes of treatment for glaucoma.
Dr. Serle is involved in numerous ophthalmic organizations. She is the Program Chairman of the New York Glaucoma Society, Vice President of the NYC chapter of Women in Ophthalmology, and a member of the Editorial Board of the Journal of Glaucoma. She is a past President of the New York Society for Clinical Ophthalmology, and has been the Glaucoma Editor for Focal Points, a continuing Medical Education publication for the American Academy of Ophthalmology.
Dr. Serle's practice is limited to glaucoma. Her expertise includes medical and surgical management of congenital, pediatric and adult glaucomas.
In the News: Dr. Janet Serle discusses glaucoma in The Daily News feature The Daily Check Up.
- A Prospective Observational Study Comparing the Effectiveness of Treatment Strategies for Primary Open-Angle Glaucoma
- Baerveldt Plate Area Comparison
- Intraocular Pressure Lowering Drugs
- The Effect of Selective Laser Trabeculoplasty on Intraocular Pressure Control in Glaucoma Patients
- Prediction of disease progression in glaucoma using HRT-3 trend-analysis
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Serle during 2012 and/or 2013. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
- Altheos, Inc.; Forest Laboratories, Inc.; Merck & Co., Inc.; ONO PHARMACEUTICAL CO., LTD.; Sucampo Pharmaceuticals, Inc.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website at http://icahn.mssm.edu/about-us/services-and-resources/faculty-resources/handbooks-and-policies/faculty-handbook. Patients may wish to ask their physician about the activities they perform for companies.